Literature DB >> 22406678

Alternariol induces DNA polymerase β expression through the PKA-CREB signaling pathway.

Jimin Zhao1, Kangdong Liu, Jing Lu, Junfen Ma, Xiaoyan Zhang, Yanan Jiang, Hongyan Yang, Ge Jin, Guoqiang Zhao, Mingyao Zhao, Ziming Dong.   

Abstract

Alternariol (AOH) is a mycotoxin of Alternaria alternata and can cause DNA damage and gene mutations. Low-dose and long-term treatment with AOH has been linked with incidence of esophageal carcinoma. DNA polymerase β (polβ) is a key enzyme in DNA base excision repair (BER). When it is overexpressed or mutated in cells, DNA polβ can cause genetic instability. Elevated DNA polβ has also been reported in several human cancers. Here, we report that AOH at 2, 10, 20 µM induces DNA polβ expression. In the process, protein kinase A (PKA) catalytic subunit activation, nuclear translocation and cAMP response element binding protein (CREB) phosphorylation are involved. AOH also increased CREB binding to the cAMP response element (CRE) consensus motif, which is present in the DNA polβ gene promoter. The PKA inhibitor H89 was able to block AOH-induced PKA-CREB activation, CREB DNA binding activity and decrease DNA polβ expression. Our results suggest that AOH can upregulate DNA polβ expression through the PKA-CREB signal transduction pathway.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22406678     DOI: 10.3892/ijo.2012.1398

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  5 in total

1.  Involvement of p38MAPK-ATF2 signaling pathway in alternariol induced DNA polymerase β expression.

Authors:  Jimin Zhao; Junfen Ma; Jing Lu; Yanan Jiang; Yanyan Zhang; Xiaoyan Zhang; Jun Zhao; Hongyan Yang; Youtian Huang; Mingyao Zhao; Kangdong Liu; Ziming Dong
Journal:  Oncol Lett       Date:  2016-06-01       Impact factor: 2.967

2.  Enhancement of silencing DNA polymerase β on the radiotherapeutic sensitivity of human esophageal carcinoma cell lines.

Authors:  Yuanyuan Wang; Xiaonan Chen; Xuanyu Hu; Ren Zhang; Yuwen Du; Wenqiao Zang; Ziming Dong; Guoqiang Zhao
Journal:  Tumour Biol       Date:  2014-10

Review 3.  Prostaglandin Pathways: Opportunities for Cancer Prevention and Therapy.

Authors:  Qiushi Wang; Rebecca J Morris; Ann M Bode; Tianshun Zhang
Journal:  Cancer Res       Date:  2022-03-15       Impact factor: 13.312

4.  High mobility group Box-1 inhibits cancer cell motility and metastasis by suppressing activation of transcription factor CREB and nWASP expression.

Authors:  Zhenghong Zuo; Xun Che; Yulei Wang; Bowen Li; Jingxia Li; Wei Dai; Charles P Lin; Chuanshu Huang
Journal:  Oncotarget       Date:  2014-09-15

5.  Pulmonary ORMDL3 is critical for induction of Alternaria-induced allergic airways disease.

Authors:  Stephan Löser; Lisa G Gregory; Youming Zhang; Katrein Schaefer; Simone A Walker; James Buckley; Laura Denney; Charlotte H Dean; William O C Cookson; Miriam F Moffatt; Clare M Lloyd
Journal:  J Allergy Clin Immunol       Date:  2016-09-10       Impact factor: 10.793

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.